The tumorigenic impact of WT PDGFRA may also be context‐dependent as PDGFRA overexpression with Ink4a/Arf tumor suppressor deletion promotes gliomagenesis (Liu et al., 2011). The gene discussed is CDKN2A; the disease is neoplasm.